{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T14:29:12Z","timestamp":1787927352464,"version":"build-2784847793"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004593","name":"Universidad Aut\u00f3noma de Madrid","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004593","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Complicated urinary tract infections (cUTIs) are a frequent indication for admission to Hospital-at-Home (HaH) and outpatient parenteral antimicrobial therapy (OPAT) programmes. We describe the clinical, urological and microbiological profile, antimicrobial treatment and outcomes of a cUTI cohort managed in a HaH unit, and explored, in an exploratory analysis, factors associated with the 30-day composite of unplanned readmission or death.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Prospective observational single-centre cohort of 262 consecutive cUTI episodes managed in a tertiary HaH unit (March 2023-October 2025). Baseline, urological, microbiological, treatment and outcome variables were recorded prospectively. Bivariate comparisons and an exploratory multivariable logistic regression were used to examine associations with the composite endpoint.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Median age was 79.7 years (Q1-Q3 66.1\u201387.2); 76.0% had multimorbidity. Escherichia coli was the most frequent isolate (45.4%; 41.2% ESBL-producing, 95% CI 32.7\u201350.2%), and the overall rate of resistance-mechanism-positive isolates was 30.2% (95% CI 24.9\u201336.0%). Ertapenem (42.8%) and ceftriaxone (41.2%) were the most frequently used intravenous agents. Clinical cure occurred in 92.0% (95% CI 88.1\u201394.7%) of episodes and 5.3% (95% CI 3.2\u20138.8%) required unplanned transfer to conventional care, with no deaths during the HaH episode. Within 30 days, 11.5% of episodes (95% CI 8.1\u201315.9%) were followed by hospital readmission and 4.2% (95% CI 2.4\u20137.4%) by death (composite endpoint, 13.4%, 95% CI 9.8\u201318.0%). In exploratory, hypothesis-generating analyses limited by the small number of events, older age and prior urological manipulation were identified as potential factors associated with the composite endpoint (age: OR 1.05, 95% CI 1.01\u20131.10; prior urological manipulation: OR 2.98, 95% CI 1.12\u20137.98), with wide confidence intervals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this single-centre, uncontrolled descriptive cohort, cUTI managed through HaH\/OPAT was associated with high clinical cure and low unplanned transfer, despite a substantial burden of ESBL-producing organisms and other resistance-mechanism-positive isolates. Older age and prior urological manipulation emerged as potential markers associated with adverse outcomes, warranting further characterisation in larger, adequately powered cohorts before informing risk stratification at HaH admission.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10096-026-05648-5","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:47:47Z","timestamp":1787924867000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and microbiological characteristics and outcomes of complicated urinary tract infections managed in a hospital-at-home programme: a prospective observational cohort study"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8954-5351","authenticated-orcid":false,"given":"Lira","family":"Pelari-Mici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9404-6415","authenticated-orcid":false,"given":"Elena","family":"Arranz Canales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5343-9541","authenticated-orcid":false,"given":"Alexia Constanza","family":"Espi\u00f1o \u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0693-9667","authenticated-orcid":false,"given":"Eva Mar\u00eda","family":"Fern\u00e1ndez Bermejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0203-2355","authenticated-orcid":false,"given":"\u00c1ngela","family":"S\u00e1nchez Juez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3326-4896","authenticated-orcid":false,"given":"Victoria","family":"Guti\u00e9rrez G\u00f3mez-Lus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1652-4622","authenticated-orcid":false,"given":"Fernando","family":"Ruiz Berraco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5212-6940","authenticated-orcid":false,"given":"Saida","family":"Alonso Marrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3734-3393","authenticated-orcid":false,"given":"Jaime","family":"Bustos Carpio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0809-9944","authenticated-orcid":false,"given":"Jos\u00e9","family":"Curbelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0091-6209","authenticated-orcid":false,"given":"Eduardo","family":"Albers Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1321-0616","authenticated-orcid":false,"given":"Pablo","family":"Rodr\u00edguez-Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"5648_CR1","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.3390\/microorganisms12112114","volume":"12","author":"A Artero","year":"2024","unstructured":"Artero A, L\u00f3pez-Cruz I, Aguilera JA et al (2024) recurrent urinary tract infections in older adults requiring hospitalization in an internal medicine ward. Microorganisms 12:2114. https:\/\/doi.org\/10.3390\/microorganisms12112114","journal-title":"Microorganisms"},{"key":"5648_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/cid\/ciy418","volume":"68","author":"N Eliakim-Raz","year":"2019","unstructured":"Eliakim-Raz N, Babitch T, Shaw E et al (2019) risk factors for treatment failure and mortality among hospitalized patients with complicated urinary tract infection: A Multicenter Retrospective Cohort Study (RESCUING Study Group). Clin Infect Dis Off Publ Infect Dis Soc Am 68:29\u201336. https:\/\/doi.org\/10.1093\/cid\/ciy418","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"5648_CR3","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s40121-025-01149-8","volume":"14","author":"E Broughton","year":"2025","unstructured":"Broughton E, Bektas M, Colosia A et al (2025) A systematic literature review of the epidemiology of complicated urinary tract infection. Infect Dis Ther 14:1157\u20131181. https:\/\/doi.org\/10.1007\/s40121-025-01149-8","journal-title":"Infect Dis Ther"},{"key":"5648_CR4","doi-asserted-by":"publisher","first-page":"6926","DOI":"10.1038\/s41598-021-86246-7","volume":"11","author":"T Babich","year":"2021","unstructured":"Babich T, Eliakim-Raz N, Turjeman A et al (2021) Risk factors for hospital readmission following complicated urinary tract infection. Sci Rep 11:6926. https:\/\/doi.org\/10.1038\/s41598-021-86246-7","journal-title":"Sci Rep"},{"key":"5648_CR5","doi-asserted-by":"publisher","first-page":"e0223130","DOI":"10.1371\/journal.pone.0223130","volume":"14","author":"DL Fink","year":"2019","unstructured":"Fink DL, Collins S, Barret R et al (2019) Shortening duration of ertapenem in outpatient parenteral antimicrobial therapy for complicated urinary tract infections: A retrospective study. PLoS ONE 14:e0223130. https:\/\/doi.org\/10.1371\/journal.pone.0223130","journal-title":"PLoS ONE"},{"key":"5648_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1136\/qshc.2002.003822","volume":"13","author":"TA Brennan","year":"2004","unstructured":"Brennan TA, Leape LL, Laird NM et al (2004) Incidence of adverse events and negligence in hospitalized patients: results of the Harvard Medical Practice Study I. BMJ Qual Saf 13:145\u2013151. https:\/\/doi.org\/10.1136\/qshc.2002.003822","journal-title":"BMJ Qual Saf"},{"key":"5648_CR7","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1001\/jama.2011.1556","volume":"306","author":"KE Covinsky","year":"2011","unstructured":"Covinsky KE, Pierluissi E, Johnston CB (2011) Hospitalization-associated disability: She was probably able to ambulate, but I\u2019m not sure. JAMA 306:1782\u20131793. https:\/\/doi.org\/10.1001\/jama.2011.1556","journal-title":"JAMA"},{"key":"5648_CR8","doi-asserted-by":"publisher","first-page":"e2111568","DOI":"10.1001\/jamanetworkopen.2021.11568","volume":"4","author":"G Arsenault-Lapierre","year":"2021","unstructured":"Arsenault-Lapierre G, Henein M, Gaid D et al (2021) Hospital-at-home interventions vs in-hospital stay for patients with chronic disease who present to the emergency department: A Systematic Review and Meta-analysis. JAMA Netw Open 4:e2111568. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.11568","journal-title":"JAMA Netw Open"},{"key":"5648_CR9","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1001\/jamainternmed.2016.5974","volume":"176","author":"J Conley","year":"2016","unstructured":"Conley J, O\u2019Brien CW, Leff BA et al (2016) alternative strategies to inpatient hospitalization for acute medical conditions: A Systematic Review. JAMA Intern Med 176:1693\u20131702. https:\/\/doi.org\/10.1001\/jamainternmed.2016.5974","journal-title":"JAMA Intern Med"},{"key":"5648_CR10","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1377\/hlthaff.2011.1132","volume":"31","author":"L Cryer","year":"2012","unstructured":"Cryer L, Shannon SB, Van Amsterdam M, Leff B (2012) Costs for \u2018hospital at home\u2019 patients were 19% lower, with equal or better outcomes compared to similar inpatients. Health Aff (Millwood) 31:1237\u20131243. https:\/\/doi.org\/10.1377\/hlthaff.2011.1132","journal-title":"Health Aff (Millwood)"},{"key":"5648_CR11","doi-asserted-by":"publisher","first-page":"798","DOI":"10.7326\/0003-4819-143-11-200512060-00008","volume":"143","author":"B Leff","year":"2005","unstructured":"Leff B, Burton L, Mader SL et al (2005) Hospital at home: feasibility and outcomes of a program to provide hospital-level care at home for acutely Ill older patients. Ann Intern Med 143:798\u2013808. https:\/\/doi.org\/10.7326\/0003-4819-143-11-200512060-00008","journal-title":"Ann Intern Med"},{"key":"5648_CR12","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1093\/jac\/dkp343","volume":"64","author":"ALN Chapman","year":"2009","unstructured":"Chapman ALN, Dixon S, Andrews D et al (2009) Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective. J Antimicrob Chemother 64:1316\u20131324. https:\/\/doi.org\/10.1093\/jac\/dkp343","journal-title":"J Antimicrob Chemother"},{"key":"5648_CR13","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ijantimicag.2012.01.016","volume":"39","author":"DA Barr","year":"2012","unstructured":"Barr DA, Semple L, Seaton RA (2012) Outpatient parenteral antimicrobial therapy (OPAT) in a teaching hospital-based practice: a retrospective cohort study describing experience and evolution over 10 years. Int J Antimicrob Agents 39:407\u2013413. https:\/\/doi.org\/10.1016\/j.ijantimicag.2012.01.016","journal-title":"Int J Antimicrob Agents"},{"key":"5648_CR14","doi-asserted-by":"publisher","first-page":"107263","DOI":"10.1016\/j.ijantimicag.2024.107263","volume":"64","author":"SA Mohammed","year":"2024","unstructured":"Mohammed SA, Roberts JA, Cotta MO et al (2024) Safety and efficacy of outpatient parenteral antimicrobial therapy: A systematic review and meta-analysis of randomized clinical trials. Int J Antimicrob Agents 64:107263. https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107263","journal-title":"Int J Antimicrob Agents"},{"key":"5648_CR15","doi-asserted-by":"publisher","first-page":"102938","DOI":"10.1016\/j.jiph.2025.102938","volume":"18","author":"SA Mohammed","year":"2025","unstructured":"Mohammed SA, Roberts N, Nicol\u00e1s D et al (2025) Implementation of outpatient parenteral antimicrobial therapy program in the contemporary health care system: A narrative review of the evidence. J Infect Public Health 18:102938. https:\/\/doi.org\/10.1016\/j.jiph.2025.102938","journal-title":"J Infect Public Health"},{"key":"5648_CR16","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2217\/fmb.15.141","volume":"11","author":"M Mir\u00f3n-Rubio","year":"2016","unstructured":"Mir\u00f3n-Rubio M, Gonz\u00e1lez-Ramallo V, Estrada-Cuxart O et al (2016) Intravenous antimicrobial therapy in the hospital-at-home setting: data from the Spanish Outpatient Parenteral Antimicrobial Therapy Registry. Future Microbiol 11:375\u2013390. https:\/\/doi.org\/10.2217\/fmb.15.141","journal-title":"Future Microbiol"},{"key":"5648_CR17","first-page":"313","volume":"29","author":"M Soledad Gallardo","year":"2017","unstructured":"Soledad Gallardo M, Ant\u00f3n A, Pulido Herrero E et al (2017) [Effectiveness of a home hospitalization program for patients with urinary tract infection after discharge from an emergency department]. Emerg Rev Soc Esp Med Emerg 29:313\u2013319","journal-title":"Emerg Rev Soc Esp Med Emerg"},{"key":"5648_CR18","doi-asserted-by":"publisher","first-page":"100212","DOI":"10.1016\/j.clinpr.2022.100212","volume":"17","author":"S Shakoor","year":"2023","unstructured":"Shakoor S, Durojaiye OC, Collini PJ (2023) Outcomes of outpatient parenteral antimicrobial therapy (OPAT) for urinary tract infections \u2013 A single center retrospective cohort study. Clin Infect Pract 17:100212. https:\/\/doi.org\/10.1016\/j.clinpr.2022.100212","journal-title":"Clin Infect Pract"},{"key":"5648_CR19","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1097\/UPJ.0000000000000647","volume":"11","author":"K Hanchate","year":"2024","unstructured":"Hanchate K, Pathak RA, Thiel DD et al (2024) Initial Experience With Inpatient Hospital Care at Home for Urologic Disease. Urol Pract 11:975\u2013981. https:\/\/doi.org\/10.1097\/UPJ.0000000000000647","journal-title":"Urol Pract"},{"key":"5648_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.eururo.2024.03.035","volume":"86","author":"J Kranz","year":"2024","unstructured":"Kranz J, Bartoletti R, Bruy\u00e8re F et al (2024) European association of urology guidelines on urological infections: summary of the 2024 Guidelines. Eur Urol 86:27\u201341. https:\/\/doi.org\/10.1016\/j.eururo.2024.03.035","journal-title":"Eur Urol"},{"key":"5648_CR21","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.idc.2024.03.010","volume":"38","author":"JE Lazarus","year":"2024","unstructured":"Lazarus JE, Gupta K (2024) Recurrent UTI in women\u2013risk factors and management. Infect Dis Clin North Am 38:325\u2013341. https:\/\/doi.org\/10.1016\/j.idc.2024.03.010","journal-title":"Infect Dis Clin North Am"},{"key":"5648_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/bju.15756","volume":"3","author":"M Kwok","year":"2022","unstructured":"Kwok M, McGeorge S, Mayer-Coverdale J et al (2022) Guideline of guidelines: management of recurrent urinary tract infections in women. BJU Int 130 Suppl 3:11\u201322. https:\/\/doi.org\/10.1111\/bju.15756","journal-title":"BJU Int 130 Suppl"},{"key":"5648_CR23","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrmicro3432","volume":"13","author":"AL Flores-Mireles","year":"2015","unstructured":"Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ (2015) Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol 13:269\u2013284. https:\/\/doi.org\/10.1038\/nrmicro3432","journal-title":"Nat Rev Microbiol"},{"key":"5648_CR24","doi-asserted-by":"publisher","first-page":"222","DOI":"10.5301\/uro.5000092","volume":"81","author":"V Iacovelli","year":"2014","unstructured":"Iacovelli V, Gaziev G, Topazio L et al (2014) Nosocomial urinary tract infections: A review. Urologia 81:222\u2013227. https:\/\/doi.org\/10.5301\/uro.5000092","journal-title":"Urologia"},{"key":"5648_CR25","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW et al (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315:801\u2013810. https:\/\/doi.org\/10.1001\/jama.2016.0287","journal-title":"JAMA"},{"key":"5648_CR26","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373\u2013383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8","journal-title":"J Chronic Dis"},{"key":"5648_CR27","first-page":"61","volume":"14","author":"FI Mahoney","year":"1965","unstructured":"Mahoney FI, Barthel DW (1965) functional evaluation: the barthel index. Md State Med J 14:61\u201365","journal-title":"Md State Med J"},{"key":"5648_CR28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12877-018-0718-2","volume":"18","author":"J Ambl\u00e0s-Novellas","year":"2018","unstructured":"Ambl\u00e0s-Novellas J, Martori JC, Espaulella J et al (2018) Frail-VIG index: a concise frailty evaluation tool for rapid geriatric assessment. BMC Geriatr 18:29. https:\/\/doi.org\/10.1186\/s12877-018-0718-2","journal-title":"BMC Geriatr"},{"key":"5648_CR29","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3390\/antibiotics10050585","volume":"10","author":"D Rozenkiewicz","year":"2021","unstructured":"Rozenkiewicz D, Esteve-Palau E, Arenas-Miras M et al (2021) clinical and economic impact of community-onset urinary tract infections caused by ESBL-producing Klebsiella pneumoniae requiring hospitalization in Spain: An Observational Cohort Study. Antibiotics 10:585. https:\/\/doi.org\/10.3390\/antibiotics10050585","journal-title":"Antibiotics"},{"key":"5648_CR30","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","volume":"8","author":"JDD Pitout","year":"2008","unstructured":"Pitout JDD, Laupland KB (2008) Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 8:159\u2013166. https:\/\/doi.org\/10.1016\/S1473-3099(08)70041-0","journal-title":"Lancet Infect Dis"},{"key":"5648_CR31","first-page":"252","volume":"15","author":"SD Phipps","year":"2011","unstructured":"Phipps SD, Peacock GF, Smith DL (2011) Stability of ertapenem in an elastomeric infusion device. Int J Pharm Compd 15:252\u2013254","journal-title":"Int J Pharm Compd"},{"key":"5648_CR32","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s10096-015-2330-0","volume":"34","author":"A Mujal","year":"2015","unstructured":"Mujal A, Sola J, Hernandez M et al (2015) Safety and effectiveness of home intravenous antibiotic therapy for multidrug-resistant bacterial infections. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol 34:1125\u20131133. https:\/\/doi.org\/10.1007\/s10096-015-2330-0","journal-title":"Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol"},{"key":"5648_CR33","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.3390\/antibiotics11081124","volume":"11","author":"S Ortonobes","year":"2022","unstructured":"Ortonobes S, Mujal-Mart\u00ednez A, De Castro Julve M et al (2022) Successful integration of clinical pharmacists in an OPAT program: A Real-Life Multidisciplinary Circuit. Antibiotics 11:1124. https:\/\/doi.org\/10.3390\/antibiotics11081124","journal-title":"Antibiotics"},{"key":"5648_CR34","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s15010-020-01398-4","volume":"48","author":"C Quintens","year":"2020","unstructured":"Quintens C, Steffens E, Jacobs K et al (2020) Efficacy and safety of a Belgian tertiary care outpatient parenteral antimicrobial therapy (OPAT) program. Infection 48:357\u2013366. https:\/\/doi.org\/10.1007\/s15010-020-01398-4","journal-title":"Infection"},{"key":"5648_CR35","doi-asserted-by":"publisher","first-page":"e14230","DOI":"10.1111\/ijcp.14230","volume":"75","author":"A Nazli Zeka","year":"2021","unstructured":"Nazli Zeka A, Avkan-Oguz V, Irmak C et al (2021) Daily inpatient ertapenem therapy can be an alternative to hospitalization for the treatment of complicated urinary tract infections during the COVID-19 pandemic. Int J Clin Pract 75:e14230. https:\/\/doi.org\/10.1111\/ijcp.14230","journal-title":"Int J Clin Pract"},{"key":"5648_CR36","volume-title":"Hospital Universitario de La Princesa. Bolet\u00edn informativo de sensibilidad a antibi\u00f3ticos y microorganismos multirresistentes del a\u00f1o 2025","author":"Servicio de Microbiolog\u00eda","year":"2025","unstructured":"Servicio de Microbiolog\u00eda (2025) Hospital Universitario de La Princesa. Bolet\u00edn informativo de sensibilidad a antibi\u00f3ticos y microorganismos multirresistentes del a\u00f1o 2025. Hospital Universitario de La Princesa, Madrid"},{"key":"5648_CR37","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.regg.2014.04.003","volume":"50","author":"M\u00c0 Mas","year":"2015","unstructured":"Mas M\u00c0, Santaeug\u00e8nia S (2015) [Hospital-at-home in older patients: a scoping review on opportunities of developing comprehensive geriatric assessment based services]. Rev Esp Geriatr Gerontol 50:26\u201334. https:\/\/doi.org\/10.1016\/j.regg.2014.04.003","journal-title":"Rev Esp Geriatr Gerontol"},{"key":"5648_CR38","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.7326\/L21-0614","volume":"174","author":"DM Levine","year":"2021","unstructured":"Levine DM, Montalto M, Leff B (2021) Is comprehensive geriatric assessment admission avoidance hospital at home an alternative to hospital admission for older persons? Ann Intern Med 174:1633. https:\/\/doi.org\/10.7326\/L21-0614","journal-title":"Ann Intern Med"},{"key":"5648_CR39","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s00192-022-05320-4","volume":"34","author":"CEL Moreno","year":"2023","unstructured":"Moreno CEL, Velandia OMM, S\u00e1nchez CAB et al (2023) Impact of urinary catheter on resistance patterns and clinical outcomes on complicated urinary tract infection. Int Urogynecol J 34:1195\u20131201. https:\/\/doi.org\/10.1007\/s00192-022-05320-4","journal-title":"Int Urogynecol J"},{"key":"5648_CR40","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"A-P Magiorakos","year":"2012","unstructured":"Magiorakos A-P, Srinivasan A, Carey RB et al (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 18:268\u2013281. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-026-05648-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-026-05648-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-026-05648-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:47:49Z","timestamp":1787924869000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-026-05648-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":40,"alternative-id":["5648"],"URL":"https:\/\/doi.org\/10.1007\/s10096-026-05648-5","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"assertion":[{"value":"19 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Research Ethics Committee of Hospital Universitario de La Princesa (protocol no. 5605, CEIm 12\/24, 20 June 2024).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Given the observational design and the use of anonymised, prospectively recorded data from routine HaH care, the Research Ethics Committee waived the requirement for individual informed consent.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. The manuscript does not contain any individual person\u2019s data in any form (including any individual details, images or videos).","order":3,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}